2012-08-09 – Page 3 – China Stock Advice

CBPO [China Biologic Products] 8-K: (Original Filing)

[China Biologic Reports Financial Results for the 2Q12 Total Sales Up 21.1% to $50.5 Million Up 52.2% to $13.3 Million BEIJING, China August 9, 2012 Second Quarter 2012 Financial Highlights Total sales Gross profit Income from operations Net income attributable to the Company Non-GAAP adjusted net income attributable to the Company Mr. David (Xiaoying) Gao, Chairman and chief] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): August 9, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) 18th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 Peoples Republic of China 86-10-6698-3166 (Former name or former address,]

By info| 2016-04-03T01:17:52+00:00 August 9th, 2012|Categories: CBPO, Chinese Stocks, SEC Original|Tags: 0001369868, 2012-08-09, 2836, 8-K, BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES), CBPO|0 Comments

NOAH [Noahs] 6-K: NOAHS LIMITED Tao Thomas Wu Chief Financial Officer

[NOAHS LIMITED Tao Thomas Wu Chief Financial Officer STYLE="font-family:Times New Roman" SIZE="2">NOAHS LIMITED ANNOUNCES UNAUDITED FINANCIAL RESULTS FOR THE SECOND QUARTER OF 2012 SHANGHAI, CHINA August8, 2012 Noahs Limited (Noah or thempany) (NYSE: NOAH), the leading independent service provider focusing on distributing wealth management products to the high net worth population in China, today announced]

By info| 2016-02-07T13:40:54+00:00 August 9th, 2012|Categories: Chinese Stocks, NOAH, Webplus ver|Tags: 0001499543, 2012-08-09, 6-K, 6282, INVESTMENT ADVICE, NOAH|0 Comments

SIMO [Silicon Motion Technology] 6-K: Silicon Motion Announces Departure of Henry Chen as

[Silicon Motion Announces Departure of Henry Chen as a Member of the Board of Directors Taipei, Taiwan, August 8, 2012 Silicon Motion Technology Corporation (NasdaqGS: SIMO) (Silicon Motion or the Company) announced today that Henry Chen resigned from the Companys Board of Directors, effective July 31, 2012. His replacement will be elected during the Companys upcoming annual shareholders meeting.] [Press Release issued by the Company on August 8, 2012. ILICON OTION]

By info| 2016-03-14T19:22:53+00:00 August 9th, 2012|Categories: Chinese Stocks, SIMO, Webplus ver|Tags: 0001329394, 2012-08-09, 3674, 6-K, SEMICONDUCTORS and RELATED DEVICES, SIMO|0 Comments

CBPO [China Biologic Products] 8-K: China Biologic Reports Financial Results for the 2Q12

[China Biologic Reports Financial Results for the 2Q12 Total Sales Up 21.1% to $50.5 Million Up 52.2% to $13.3 Million BEIJING, China August 9, 2012 Second Quarter 2012 Financial Highlights Total sales Gross profit Income from operations Net income attributable to the Company Non-GAAP adjusted net income attributable to the Company Mr. David (Xiaoying) Gao, Chairman and chief] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): August 9, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) 18th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 Peoples Republic of China 86-10-6698-3166 (Former name or former address,]

By info| 2016-04-03T01:18:43+00:00 August 9th, 2012|Categories: CBPO, Chinese Stocks, Webplus ver|Tags: 0001369868, 2012-08-09, 2836, 8-K, BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES), CBPO|0 Comments

GURE [GULF RESOURCES] 10-Q: (Original Filing)

[Part I – Financial Information Item 1. Financial Statements 1 Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 20 Item 3. Quantitative and Qualitative Disclosures about Market Risk 39 Item 4. Controls and Procedures 40 Part II – Other Information Item 1. Legal Proceedings 40 Item 1A. Risk Factors 41 Item 2. Unregistered Shares of] [Certification of Chief Executive Officer I, Xiaobin Liu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q for the period ended June 30, 2012 of Gulf Resources, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [Certification of Chief Financial Officer I, Min Li, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q for the period ended June 30, 2012 of Gulf Resources, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [18 U.S.C. SECTION 1350 AND EXCHANGE ACT RULES 13a-14(b) AND 15d-14(b) (Section 906 of the Sarbanes-Oxley Act of 2002) (1) (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of the operation of the Company. Dated: August 9, 2012 Xiaobin Liu Chief Executive Officer and President Dated: August 9, 2012 Min]

By info| 2016-03-18T05:24:43+00:00 August 9th, 2012|Categories: Chinese Stocks, GURE, SEC Original|Tags: 0000885462, 10-Q, 2012-08-09, 2800, CHEMICALS and ALLIED PRODUCTS, GURE|0 Comments

CBPO [China Biologic Products] 10-Q: (Original Filing)

[FORM 10 - Q (Mark One) [X] For the quarterly period ended: June 30, 2012 [ ] For the transition period from _________________to________________ CHINA BIOLOGIC PRODUCTS, INC. Delaware 75-2308816 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) 18th Floor, Jialong International Building Chaoyang District, Beijing 100125 (+86) 10-6598-3111 _____________________________________________________ Yes [X] No [ ] Yes [X]] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th (Principal Financial Officer)]

By info| 2016-04-03T01:20:36+00:00 August 9th, 2012|Categories: CBPO, Chinese Stocks, SEC Original|Tags: 0001369868, 10-Q, 2012-08-09, 2836, BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES), CBPO|0 Comments

GURE [GULF RESOURCES] 10-Q: Part I – Financial Information Item 1. Financial

[Part I – Financial Information Item 1. Financial Statements 1 Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 20 Item 3. Quantitative and Qualitative Disclosures about Market Risk 39 Item 4. Controls and Procedures 40 Part II – Other Information Item 1. Legal Proceedings 40 Item 1A. Risk Factors 41 Item 2. Unregistered Shares of] [Certification of Chief Executive Officer I, Xiaobin Liu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q for the period ended June 30, 2012 of Gulf Resources, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [Certification of Chief Financial Officer I, Min Li, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q for the period ended June 30, 2012 of Gulf Resources, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [18 U.S.C. SECTION 1350 AND EXCHANGE ACT RULES 13a-14(b) AND 15d-14(b) (Section 906 of the Sarbanes-Oxley Act of 2002) (1) (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of the operation of the Company. Dated: August 9, 2012 Xiaobin Liu Chief Executive Officer and President Dated: August 9, 2012 Min]

By info| 2016-03-18T05:25:38+00:00 August 9th, 2012|Categories: Chinese Stocks, GURE, Webplus ver|Tags: 0000885462, 10-Q, 2012-08-09, 2800, CHEMICALS and ALLIED PRODUCTS, GURE|0 Comments

CBPO [China Biologic Products] 10-Q: FORM 10 – Q (Mark One) [X] For

[FORM 10 - Q (Mark One) [X] For the quarterly period ended: June 30, 2012 [ ] For the transition period from _________________to________________ CHINA BIOLOGIC PRODUCTS, INC. Delaware 75-2308816 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) 18th Floor, Jialong International Building Chaoyang District, Beijing 100125 (+86) 10-6598-3111 _____________________________________________________ Yes [X] No [ ] Yes [X]] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th (Principal Financial Officer)]

By info| 2016-04-03T01:21:38+00:00 August 9th, 2012|Categories: CBPO, Chinese Stocks, Webplus ver|Tags: 0001369868, 10-Q, 2012-08-09, 2836, BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES), CBPO|0 Comments

SYUT [Synutra International] 10-Q: (Original Filing)

[FORM 10-Q x For the quarterly period ended June 30, 2012 OR o For the transition period from SYNUTRA INTERNATIONAL, INC. DELAWARE 13-4306188 (State or Other Jurisdiction of Incorporation or Organization) I.R.S. Employer Identification No. 2275 Research Blvd., Suite 500 Rockville, Maryland 20850 (301) 840-3888 x o x o] [CERTIFICATION I, Liang Zhang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Synutra International, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Weiguo Zhang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Synutra International, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [SYNUTRA INTERNATIONAL, INC. Certification Liang Zhang Chief Executive Officer] [SYNUTRA INTERNATIONAL, INC. Certification Weiguo Zhang Interim Chief Financial Officer]

By info| 2016-03-18T18:16:42+00:00 August 9th, 2012|Categories: Chinese Stocks, SEC Original, SYUT|Tags: 0001293593, 10-Q, 2012-08-09, 2020, DAIRY PRODUCTS, SYUT|0 Comments

CBPO [China Biologic Products] 8-K: (Original Filing)

[FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): August 7, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) 18th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 Peoples Republic of China 86-10-6698-3166 (Former name or former address,]

By info| 2016-04-03T01:22:53+00:00 August 9th, 2012|Categories: CBPO, Chinese Stocks, SEC Original|Tags: 0001369868, 2012-08-09, 2836, 8-K, BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES), CBPO|0 Comments